Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.08.2023 | Case report

Pyrotinib

Diarrhoea, vomiting and abnormal hepatic function: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Mao S, et al. Outcome comparison of pyrotinib with current standard of care in the second/third line setting in advanced non-small cell lung cancer patients with HER2 mutation. Chinese Medical Journal 136: 848-850, No. 7, et al. Apr 2023. Available from: URL: http://doi.org/10.1097/CM9.0000000000002453 Mao S, et al. Outcome comparison of pyrotinib with current standard of care in the second/third line setting in advanced non-small cell lung cancer patients with HER2 mutation. Chinese Medical Journal 136: 848-850, No. 7, et al. Apr 2023. Available from: URL: http://​doi.​org/​10.​1097/​CM9.​0000000000002453​
Metadaten
Titel
Pyrotinib
Diarrhoea, vomiting and abnormal hepatic function: case report
Publikationsdatum
01.08.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-45352-9

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Gabapentin